7.23.2020. Cornerstone Government Affairs COVID-19 Legislative Update

Legislation
Supplemental IV
Timeline: After a couple fire drills between the White House and Senate Republicans, Leader McConnell said on the Senate floor today that Republicans will be releasing the bill early next week . He indicated that various Senate Chairs and other senators will be introducing their portions of the bill on Monday. McConnell had planned to roll out the bill this morning, after reportedly reaching an agreement with the White House last night. However, some last-minute disagreements caused a delay to next week. As there are some difficult sticking points that remain to be worked out between Democrats and Republicans, negotiations will not be quick and painless – there’s no guarantee that the bill is negotiated before the July 31 unemployment insurance expiration. Last week, House Majority Leader Hoyer told members to keep the first week of August open, though now there is talk of voting during the second week of August. The Paycheck Protection Program expires on August 8.
 
Politics/Process: Republicans have been working to reach consensus over the past week, but the past two days have shown the most volatility. There were reports of Leader McConnell proposing the extension of the enhanced unemployment insurance (UI) for four months at a lower rate of $450 per week, separate from a larger package. The White House reportedly rejected that idea. Severing the UI portion of the package would take significant pressure off lawmakers to get this done quickly. Late last night the White House and Senate Republicans had reportedly reached a deal and McConnell was set to roll it out at 9:30am this morning, but that plan was quickly changed and the roll out was delayed to next week. While the plan is to begin releasing the package in pieces on Monday, we could see another delay if consensus isn’t reached. Some committees had already finished drafting text, while others may still be in process. 
 
Until Republicans introduce a bill, Democrats are in no hurry to begin negotiating with themselves . Minority Leader Schumer and Speaker Pelosi have been in constant conversation and will likely remain so. As Republicans will need 60 votes to pass the bill through the Senate, Democrats will have significant leverage once negotiations begin. Senate Majority Whip John Thune has indicated that when this is all said and done, he may lose as many as 25 Republicans on the final vote.
 
Policy: While text has yet to be finalized and there could be significant changes from now until Monday , the following represents what the White House and Senate Republicans had agreed to as of last night (agreement here ):

  • Extension of the enhanced unemployment insurance , though there will be a transition period of beneficiaries receiving a flat amount (less than $600 per week) then moving to a different policy that disallows beneficiaries from receiving more in the benefit than their previous income.
  • Extension of the Paycheck Protection Program including:
    • A second round of PPP loans for business that have 1) fewer than 300 workers, OR 2) are within an SBA-designated size threshold for their industry and can show 50% or more in lost revenue.
    • Streamlined forgiveness for loans under $150k.
    • Forgiveness to include other costs like riot damage, supplier costs, and other expenses.
    • Working capital loan for businesses with fewer than 300 workers (as an alternative to PPP).
  • Liability protections for organizations that mandate plaintiffs show defendants were grossly negligent/engaged in willful misconduct AND violated public health guidelines.
  • No funding for state, local, tribal, or territorial governments , but states may use the funding to make up lost revenues. Limitations on what states can use funding for (no funds for pensions/rainy-day fund).
  • Tax provisions including,
    • Enhanced employee retention tax credit ,
    • Tax deductions for COVID-related expenses like testing and PPE,
    • Increasing the business meal deduction to 100 percent (from 50 percent).
  • $235 billion for health , including
    • $25 billion for testing,
    • $26 billion for vaccines,
    • $15.5 billion for NIH
    • $25 billion for provider relief fund
    • $15 billion for child chare
    • $4.5 billion for SAMHSA.
  • $105 billion for education including:
    • $29 billion for higher education institutions,
    • $70 billion for K-12 (with schools receiving it within 30 days of enactment, $30 billion of this will be available only to schools that physically reopen).
  • Another round of economic stimulus payment (eligibility and amount TBD).
  • Medicare and Medicaid provisions including:
    • Part B premium freeze until 2022,
    • Extension of telemedicine reimbursement through 2021,
    • Extended timeline for providers to repay Medicare Advances.
  • $302 billion for appropriations including:
    • $235 billion for Labor HHS (referenced above),
    • $20 billion Agriculture,
    • $21.3 billion for Defense ($11 billion for 3610 payments),
    • $13 billion for THUD,
    • ~$3 billion for Homeland (almost $1 billion for FEMA grants, $1.6 billion to CBP),
    • $5 billion for SFOPS.

Democrats have continued to roll out new proposals (Sen. Wyden and Leader Schumer proposal on unemployment insurance, white papers on health care and testing) and highlight various provisions from the Heroes Act. Beyond extending unemployment insurance, funding for state/local/tribes, and funding for education and health, Democrats have been highlighting many other issues, including rental assistance and supporting communities of color , which have been disproportionately impacted by the virus.
 
The House passed the Democrats’ opening bid for the next bill, the Heroes Act, on May 15. While it’s been over two months since House passage of the bill and the contours of the debate and which issues are most pressing have shifted slightly, it can still serve as a marker of what Senate Republicans will be responding to in their bill. Heroes Act text (as of 5/12/2020) here. Section by section here. One pager here. State and Local one pager here. NCAI’s summary on tribal provisions here. Manager’s amendment here. House Rules Committee report here.
 
Passed Legislation
Moving forward, this section will only include new information and guidance. For past information and guidance and legislation, please refer to the archives. For a summary of all supplementals, please see here.
 
New Implementation Information and Guidance

  • 7/21 – Treasury and SBA released new data on the Paycheck Protection Program and Economic Injury Disaster Loans (EIDL) and EIDL Advance programs. PPP data here. EIDL data here. EIDL Advance data here.
By Maria Thacker Goethe April 18, 2025
The Science & Community Impacts Mapping Project (SCIMaP) shows how proposed federal funding cuts lead to reduced economic activity and job losses nationwide.
By Sheran Brown April 10, 2025
Georgia Life Sciences Selects Fulton County Schools Innovation Academy Student as the 2025 Georgia BioGENEius Winner Sandy Springs & Rockmart Teens Take Top Honors in Statewide Science Competition Atlanta, GA (April 4, 2025) – Georgia Life Sciences today named Bhavya Alapati , a junior at Fulton County Schools Innovation Academy, as the winner of the 2025 Georgia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field. Eleven students from across Georgia competed for this year’s title and cash prize. Bhavya’s project investigated a novel method of identifying strokes using a device she created called SpectroStroke, a small-scale spectrophotometer, to detect homocysteine, an amino acid product that is associated with stroke. Bhavya identified the ability of homocysteine to be detected using Ellman’s reagent, which reacts with the free sulfhydryl group on the molecule to produce a yellow color. Bhavya created a wearable patch that contains the Ellman’s reagent. Then, she designed the SpectroStroke to be able to detect the color change when the patch is exposed to elevated levels of homocysteine. Bhavya’s SpectroStroke can detect normal levels of homocysteine up to extremely high levels seen in those experiencing a stroke. The ability to detect a stroke earlier would reduce damage and long-term effects of the condition. A future iteration of the SpectroStroke would include real-time monitoring capabilities to help track changing homocysteine levels. "Supporting and celebrating outstanding research and innovation in biotechnology is vital for the future of science and medicine. The Georgia BioGENEius Challenge not only encourages the brightest young minds to explore their potential but also nurtures the next generation of leaders who will drive groundbreaking advancements in biotechnology,” said Georgia Life Sciences President and CEO Maria Thacker-Goethe. “By recognizing and empowering these students, we are helping to shape a future where innovation thrives and the possibilities for improving lives are endless. Well done, Bhavya!” Georgia Life Sciences also congratulates the Georgia BioGENEius runner-up, Shelby Kendrick , who is a senior at Paulding County High School in Dallas, GA. Shelby’s research investigated the ability of Aspergillus terreus, a fungus found in soil, to degrade pre-treated polypropylene plastic (PP). This fungus has been discovered to produce high concentrations of degrading enzymes and raises the moisture level of its substrate. Shelby isolated the fungus from soil samples and confirmed the species using PCR amplification and DNA barcoding. Samples of polypropylene were pre-treated with 75% ethanol and UV exposure, then placed in a liquid culture of A. terreus in Minimal Salt Medium (MSM) media, and the culture was incubated for 23 days. At the end of the trial period, PP samples were analyzed using Scanning Electron Microscopy. These samples showed changes in their surface layer, indicating evidence of biodegradation. Polypropylene plastic is found in household items such as plastic cups and is a known problem in the environment due to its inability to degrade. Shelby’s future research on the use of A. terreus for biodegradation includes optimizing degradation conditions and assessing methods of application in the environment. Judging the 2025 Georgia BioGENEius Challenge were Ralph L. Cordell, CDC, and Alex Harvey, ViaMune. Cash prizes were awarded to Bhavya and Shelby. # # # About Georgia Life Sciences Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at galifesciences.org.
By Maria Thacker Goethe April 9, 2025
Emerging biotechnology is key for U.S. to remain dominant and secure future economic growth in a new era of global competition
MORE POSTS